SEC Form 4 · accession 0000908662-15-000054
ENANTA PHARMACEUTICALS INC · ENTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nathaniel S. Gardiner
Officer — Sr. VP & General Counsel
Period of report
Feb 13, 2015
Accepted (ET)
Feb 17, 2015 · 6:57 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001177648
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 13, 2015 | P | 400 | $33.00 | A | 400 | D | |
| Common Stock | Feb 17, 2015 | P | 600 | $33.47 | A | 1,000 | D | |
| Common Stock | Feb 17, 2015 | P | 400 | $33.10 | A | 1,400 | D |
Table II — derivative securities
No Table II lines on this filing.